Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
NEEDHAM, Mass., May 18, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a late…
News
AGTC to Present at the H.C. Wainwright Global Investment Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 18, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
AIM ImmunoTech Provides Update on Ampligen Long COVID Development Program
AIM Chief Medical Officer David Strayer, MD AIM Chief Medical Officer David Strayer, MD Charles…
Immutep Appoints Leading Oncologists to its Clinical Advisory Board
SYDNEY, AUSTRALIA, May 18, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
BioSyent Releases Financial Results for Q1 2022
MISSISSAUGA, Ontario, May 18, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released…
Morphic Appoints Joanne Gibbons as Senior Vice President of Regulatory Affairs
Experienced Regulatory Leader with Record of Global and Regulatory Success Across Multiple Therapeutic Areas WALTHAM,…
Otonomy to Participate in the H.C. Wainwright Global Investment Conference
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
Avalo Therapeutics Announces First Patient Dosed in the Phase 2 PEAK Trial of AVTX-002 for the Treatment of Non-Eosinophilic Asthma (NEA)
Topline results expected 4Q2022 WAYNE, Pa. and ROCKVILLE, Md., May 18, 2022 (GLOBE NEWSWIRE) —…
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints
Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious…
Locus Biosciences Announces $35 Million Financing
Proceeds will support product development and expansion of in-house cGMP manufacturing capabilities Company anticipates initiating…
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
Appointment brings 20 years of regulatory affairs experience and exceptional leadership capabilities CHARLOTTESVILLE, Va., May…
Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference
WALTHAM, Mass., May 18, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CARE
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR TO HOST KOL WEBINAR ON THE NEED FOR…
Immatics Announces First Patient Treated with ACTengine® IMA203 TCR-T in Combination with Checkpoint Inhibitor Opdivo® (nivolumab) in Patients with Advanced Solid Tumors
The Phase 1b dose expansion cohort will evaluate safety, biological activity and initial anti-tumor activity…
Plus Therapeutics to Present Virtually at the 2022 HC Wainwright Global Investment Conference
AUSTIN, Texas, May 18, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company…
Cabaletta Bio Presents Updated Interim DesCAARTes™ Trial Phase 1 Data at the ASGCT 25th Annual Meeting
PHILADELPHIA, May 18, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
Ikena Oncology to Participate in Spring 2022 Investor Conferences
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2
Tonix Exercises Option to License Antiviral Technology Platform NEW YORK, May 18, 2022 (GLOBE NEWSWIRE)…
IO Biotech Announces Initiation of Phase 3 Combination Trial of IO102-IO103 and KEYTRUDA® (pembrolizumab) as First-Line Treatment in Advanced Melanoma
– First Patient Dosed in Proposed Registrational Trial in Melanoma– Multiple Sites to be Opened…
Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical…